Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Bioanalysis|August 9, 2024
Quantitation of anacetrapib in human and animal adipose by liquid chromatography with mass spectrometric detectionWei Fang, Cynthia M Chavez-Eng, Ryan W Lutz, et al.
The AAPS Journal|January 11, 2014
Recommendations from the Global Bioanalysis Consortium Team A8: documentationTom Verhaeghe, Hollie H Barton, Hisanori Hara, et al.
Bioanalysis|July 11, 2020
Clinical application of volumetric absorptive microsampling to the gefapixant development programBrad Roadcap, Azher Hussain, Dan Dreyer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 31, 2011
Effect of alendronate and vitamin D₃ on fractional calcium absorption in a double-blind, randomized, placebo-controlled trial in postmenopausal osteoporotic womenSue A Shapses, David L Kendler, Richard Robson, et al.
ACS Pharmacology & Translational Science|December 21, 2020
A Tiered Approach for Characterization to Ensure Quality, Reproducibility, and Long-Term Stability of Critical Reagents in Regulated Bioanalysis to Support PK/ADA/NAb Assays for Biologics and Vaccines ProgramsKun Yang, Ying Zhang, Robert Chou, et al.
The AAPS Journal|April 6, 2022
An Investigation of Instability in Dried Blood Spot Samples for Pharmacokinetic Sampling in Phase 3 Trials of VerubecestatMelanie Anderson, Marissa F Dockendorf, Ian McIntosh, et al.
Journal of Clinical Pharmacology|December 15, 2010
Bioavailability of alendronate and vitamin D(3) in an alendronate/vitamin D(3) combination tabletAndrew E Denker, Nicole Lazarus, Arturo Porras, et al.
Bioanalysis|September 13, 2021
Cloud solutions for GxP laboratories: considerations for data storageScott Davis, Joel Usansky, Shibani Mitra-Kaushik, et al.
The AAPS Journal|January 1, 2015
Workshop report: Crystal City V--quantitative bioanalytical method validation and implementation: the 2013 revised FDA guidanceBrian Booth, Mark E Arnold, Binodh DeSilva, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 23, 2002
The disposition and metabolism of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in human subjectsRita A Halpin, Arturo G Porras, Leslie A Geer, et al.
Pageof 4